Berberine Hydrochloride Enhances the Fluconazole Susceptibility of Candida albicans through Multiple Targets
Current Microbiology · 2026-05 · 83 (5)
DOI: 10.1007/s00284-026-04805-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, online erschienen am 27.03.2026. Verfasst von Lu Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Berberine, Candida albicans, Fluconazole, Antifungal Agents. Die Arbeit nennt 47 Literaturangaben. Gefördert von: the Sichuan Provincial Science and Technology Innovation and Entrepreneurship Seedling Project.
Abstract (Originalsprache)
Candida albicans is ubiquitous on human mucosal surfaces and easy to cause infectious diseases. The widespread use of antifungal drugs has led to the increasing drug resistance of C. albicans, posing a significant challenge to clinical treatment. Berberine hydrochloride (BBH), a quaternary ammonium alkaloid isolated from Coptidis Rhizoma, exhibits broad-spectrum antifungal activity. This study explored the antifungal effect and mechanism of BBH combined with fluconazole (FLC) against drug-resistant C. albicans. Results showed that BBH could enhance the antifungal effect of FLC against the drug-resistant C. albicans. Additionally, BBH combined with FLC significantly disrupted the cell wall integrity, inhibited the formation of biofilms and hyphae, and increased the ROS levels. Transcriptome sequencing further elucidated the inhibitory mechanism of BBH combined with FLC against drug-resistant C. albicans, which primarily by affecting metabolic pathways such as cell wall biosynthesis, superoxide metabolism, and monooxygenase activity. Key genes associated with these pathways, including CHS1, SUN41, CTA1, SOD5, and HWP1, were significantly downregulated. This study primarily reveals that BBH combined with FLC exhibits significant antifungal effects against drug-resistant C. albicans. This provides new therapeutic insights and potential drug combination schemes for clinical treatment of drug-resistant C. albicans infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
- Department of Laboratory Medicine, West China, Jintang First People's Hospital, Hospital Sichuan University Jintang Hospital, Chengdu, Sichuan, China.
- School of Healthcare Technology, Chengdu Neusoft University, Chengdu, Sichuan, China.
- Department of Nuclear Medicine, Ya'an People's Hospital, Yaan, Sichuan, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
- Chengdu Anorectal Hospital, Chengdu, Sichuan, China.
Förderung
- the Sichuan Provincial Science and Technology Innovation and Entrepreneurship Seedling Project
Zitieren
APA
Yu, L., Yi, W., Zheng, W., Zheng, D., Li, J., Luo, L., Luo, G., Xia, M., You, L., & Yong, J. (2026). Berberine Hydrochloride Enhances the Fluconazole Susceptibility of Candida albicans through Multiple Targets. Current Microbiology, 83(5). https://doi.org/10.1007/s00284-026-04805-5
Vancouver
Yu L, Yi W, Zheng W, Zheng D, Li J, Luo L, et al. Berberine Hydrochloride Enhances the Fluconazole Susceptibility of Candida albicans through Multiple Targets. Current Microbiology. 2026;83(5). doi:10.1007/s00284-026-04805-5
BibTeX
@article{Yu2026,
author = {Yu, Lu and Yi, Weijia and Zheng, Wenming and Zheng, Dongming and Li, Jiaqi and Luo, Lihua and Luo, Guining and Xia, Ming and You, Li and Yong, Jiangyan},
title = {Berberine Hydrochloride Enhances the Fluconazole Susceptibility of Candida albicans through Multiple Targets},
journal = {Current Microbiology},
year = {2026},
volume = {83},
number = {5},
doi = {10.1007/s00284-026-04805-5}
}
EUVIMED